3659 results for «326»
3659 results
Rapid-fire - Nightmares in the cathlab - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...
Rapid-fire - Nightmares in the cathlab - Part 2
20 Nov 2023 – From PCR London Valves 2023
Challenges in TAVIs, are there guideline recommendations?
20 Nov 2023 – From PCR London Valves 2023
The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...
Rapid-fire - Challenging TAVI procedures - Part 4
20 Nov 2023 – From PCR London Valves 2023
Join this session for insights and innovative solutions to challenging TAVI procedures: explore the dynamics of peri-procedural ST-elevation myocardial infarction during TAVR, witness shifting left ventricular and hemodynamic physiology, unravel a curious case of valve-in-valve TAVR with a crossability challenge, confront the obstructive dilemma of high...
Rapid-fire - TAVI complications - Part 2
20 Nov 2023 – From PCR London Valves 2023
Navigate through various TAVI complications with this selection of cases: learn more about a successful coronary complication handling, gain insights into a year-long follow-up on aortic dissection post-TAVR, witness unexpected twists like late balloon aortic valvuloplasty complications, and much more!
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
TAVI - Coronary access
21 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI and coronary access with this session: explore the use of IVUS in assessing coronary arteries at high risk for obstruction following valve-in-valve TAVI, witness the application of patient-specific computer simulation to predict coronary re-access post-TAVI in bicuspid anatomy, navigate the...
Transcatheter mitral valve replacement
20 Nov 2023 – From PCR London Valves 2023
Consult this session for key insights into diverse TMVR challenges: discover unique scenarios such as para-holes post-Tendyne implant, TMVR in a patient with severe mitral annular calcification, a complex case involving mitral para-ring leak and stenosis with a two-step treatment and an atypical LAMPOON indication, and more!
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE Aapproval , its Fourth FDA IDE DEB approval
10 Jan 2023
Over 1,000 patients enrolled in landmark SELUTION DeNovo study
14 Mar 2023
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
24 Oct 2022
MedAlliance to be acquired by Cordis
18 Oct 2022
MedAlliance leads US Sirolimus DEB race: first US patient enrolled into SELUTION SLR coronary sirolimus DEB study
25 Jan 2023
MedAlliance announces enrollment of over 1,660 patients in landmark SELUTION DeNovo study
14 Sep 2023
MedAlliance acquired by Cordis for up to USD 1.135 billion
02 Oct 2023
Why hypertension is a major unresolved problem
02 Oct 2024
Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.
Author
Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial
03 Sep 2025
Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.
Author
Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure
03 Feb 2022
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention
06 Mar 2023
Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...
Author
